Preparation of high stable core/shell magnetic nanoparticles and application in Bacillus thuringiensis Cry1Ac proteins detection

2017 ◽  
Vol 241 ◽  
pp. 758-764 ◽  
Author(s):  
Jiyuan Liang ◽  
Yuxiang Wu ◽  
Cui Liu ◽  
Yuan-Cheng Cao ◽  
Jun’An Liu ◽  
...  
2020 ◽  
Vol 4 (3) ◽  
Author(s):  
C. Kons ◽  
Manh-Huong Phan ◽  
Hariharan Srikanth ◽  
D. A. Arena ◽  
Zohreh Nemati ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Chin-Wei Lin ◽  
Jian-Ming Chen ◽  
You-Jun Lin ◽  
Ling-Wei Chao ◽  
Sin-Yi Wei ◽  
...  

Abstract Recently, gold-coated magnetic nanoparticles have drawn the interest of researchers due to their unique magneto-plasmonic characteristics. Previous research has found that the magneto-optical Faraday effect of gold-coated magnetic nanoparticles can be effectively enhanced because of the surface plasmon resonance of the gold shell. Furthermore, gold-coated magnetic nanoparticles are ideal for biomedical applications because of their high stability and biocompatibility. In this work, we synthesized Fe3O4@Au core-shell nanoparticles and coated streptavidin (STA) on the surface. Streptavidin is a protein which can selectively bind to biotin with a strong affinity. STA is widely used in biotechnology research including enzyme-linked immunosorbent assay (ELISA), time-resolved immunofluorescence (TRFIA), biosensors, and targeted pharmaceuticals. The Faraday magneto-optical characteristics of the biofunctionalized Fe3O4@Au nanoparticles were measured and studied. We showed that the streptavidin-coated Fe3O4@Au nanoparticles still possessed the enhanced magneto-optical Faraday effect. As a result, the possibility of using biofunctionalized Fe3O4@Au nanoparticles for magneto-optical biomedical assays should be explored.


2014 ◽  
Vol 50 (11) ◽  
pp. 1-4 ◽  
Author(s):  
Galina V. Kurlyandskaya ◽  
Inaki Madinabeitia ◽  
A. M. Murzakaev ◽  
M. Belen Sanchez-Ilarduya ◽  
V. Beketov ◽  
...  

2003 ◽  
Vol 36 (4) ◽  
pp. 1069-1074 ◽  
Author(s):  
D. Eberbeck ◽  
A. Lange ◽  
M. Hentschel

Different very dilute suspensions of magnetic nanoparticles (magnetite surrounded by an organic shell) in water (ferrofluids) were investigated using small-angle X-ray scattering. It is shown that the scattering originates not only from noncorrelated core–shell nanoparticles, but also from larger structures. By modelling, these structures can be identified as close-packed clusters consisting of core–shell particles (core diameter ∼10 nm). The analysis of the radial distance distribution function, obtained by Fourier transformation of the scattered intensity, reveals a lower bound of the mean cluster size of about 40 nm. The formation of clusters is persistent, even in very dilute suspensions.


2019 ◽  
Vol 208 ◽  
pp. 816-826 ◽  
Author(s):  
Siow Hwa Teo ◽  
Aminul Islam ◽  
Eng Seng Chan ◽  
S.Y. Thomas Choong ◽  
Nabeel H. Alharthi ◽  
...  

2015 ◽  
Vol 92 (6) ◽  
Author(s):  
V. Dimitriadis ◽  
D. Kechrakos ◽  
O. Chubykalo-Fesenko ◽  
V. Tsiantos

2017 ◽  
Vol 10 (05) ◽  
pp. 1750056 ◽  
Author(s):  
Huiping Shao ◽  
Jiangcong Qi ◽  
Tao Lin ◽  
Yuling Zhou ◽  
Fucheng Yu

The core–shell structure composite magnetic nanoparticles (NPs), Fe3O4@chitosan@nimodipine (Fe3O4@CS@NMDP), were successfully synthesized by a chemical cross-linking method in this paper. NMDP is widely used for cardiovascular and cerebrovascular disease prevention and treatment, while CS is of biocompatibility. The composite particles were characterized by an X-ray diffractometer (XRD), a Fourier transform infrared spectroscopy (FT-IR), a transmission electron microscopy (TEM), a vibrating sample magnetometers (VSM) and a high performance liquid chromatography (HPLC). The results show that the size of the core–shell structure composite particles is ranging from 12[Formula: see text]nm to 20[Formula: see text]nm and the coating thickness of NMDP is about 2[Formula: see text]nm. The saturation magnetization of core–shell composite NPs is 46.7[Formula: see text]emu/g, which indicates a good potential application for treating cancer by magnetic target delivery. The release percentage of the NMDP can reach 57.6% in a short time of 20[Formula: see text]min in the PBS, and to 100% in a time of 60[Formula: see text]min, which indicates the availability of Fe3O4@CS@NMDP composite NPs for targeting delivery treatment.


Sign in / Sign up

Export Citation Format

Share Document